Kutanga kwaChivabvu 2023, TAGMe DNA Methylation Detection Kit(qPCR) yeUrothelial Cancer yakazvimiririra neShanghai Epiprobe Biotechnology Co., Ltd, yakawana "Breakthrough Device Designation" kubva kuUS FDA.
US FDA Breakthrough Devices Chirongwa ine chinangwa chekusimudzira kubvumidzwa kwezvigadzirwa zvevagadziri kuti vatengese munguva pfupi, uye kugonesa varwere kushandisa zvigadzirwa zvepamberi kare.
Kuti ukwanise seBreakthrough Chishandiso, zviviri zvakakosha zvinofanirwa kuzadzikiswa,
1, Aids mukurapa kwakanyanya kana kuongororwa kwezvirwere zvinotyisidzira hupenyu kana zvinopedza simba kana mamiriro.
2, Sangana nechero chimwe chezvinotevera zvinodiwa,
A, Inomiririra tekinoroji yekubudirira.
B, Hapana chakatenderwa chimwe chigadzirwa.
C, Enzanisa nezvigadzirwa zvakabvumidzwa zviripo, zvine zvakanakira zvakanakira.
D, Kushandiswa kuri mune zvakanakira murwere.
Kudomwa uku hakungorevi kuti Epiprobe's tekinoroji innovation mukuonekwa kwekutanga kenza yeurothelial yakazivikanwa nevakuru, asi zvakare inosimbisa kukosha kukuru kwekiriniki uye kukosha kwemagariro eUCOM (kenza yepasirese chete mamaki) mukuonekwa kwegomarara reurothelial.Urothelial cancer yekuona kits ichapindawo mukukurumidza kunyoresa, kushandisa uye kushambadzira muUnited States.
Nguva yekutumira: Jun-09-2023